Alembic Pharmaceuticals fixes record date for dividend
Record date is 29 July 2025Alembic Pharmaceuticals has fixed 29 July 2025 as record date for determining the entitlement of members of the Company to receive dividend for the financial year ended 31 March 2025. The payment of dividend will be made on or from Thursday, 7 August 2025, upon the same being approved at the Annual General Meeting scheduled to be held on 5 August 2025. Powered by Capital Market - Live News
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
16 hours ago
- Economic Times
At TCS AGM, AI-led disruption, automation, geopolitics in focus
The world is facing upheavals on multiple fronts—tariffs, wars, and disruption due to artificial intelligence (AI), said Keki Mistry, non-executive and independent director at Tata Consultancy Services (TCS), as he presided over the 30th Annual General Meeting (AGM) of the company. Tata Sons chairman N Chandrasekaran could not chair the meeting due to 'certain exigencies.' 'We are presently engulfed by uncertainty at multiple fronts. The global economic connections are being reconfigured on a daily basis from tariffs to supply chains, wars and conflicts across regions, to the disruption posed by artificial intelligence. The world faces upheaval at several levels,' said the veteran business executive and former CEO of HDFC. The board of directors recommended a final dividend of Rs 30 per share for the fourth quarter, which brings the total annual dividend for the year to Rs 126 per share. TCS' shareholder payout was Rs 45,588 crores with a payout ratio of 94%.Looking ahead, TCS plans to focus on four strategic pillars: establishing a large pool of AI agents working alongside the human workforce, delivering solutions to a human plus AI model, and investing in AI data centres as well as partnerships, Mistry pointed out that the geopolitical landscape has reshaped how global businesses operate—reimagining their systems, processes, and technologies. 'Among all the shifts, it is the potential of generative artificial intelligence that stands apart. Unlike previous technological revolutions, which arrived sequentially across the globe, GenAI is emerging everywhere simultaneously… GenAI is not just another tech cycle. It represents a generational shift.'
Business Standard
16 hours ago
- Business Standard
Suzlon Energy allots Equity Shares
Under ESOPSuzlon Energy has approved allotment of 36,44,500 fully paid-up equity shares of the Company having a face value of Rs.2/- each aggregating to Rs.3,30,95,500/- for cash at a premium in dematerialised form to the option grantees, pursuant to the exercise of the options granted to the eligible employees of the Company and its subsidiaries under ESOP by Capital Market - Live News
Business Standard
20 hours ago
- Business Standard
Tech Mahindra allots Equity shares
Under ESOPTech Mahindra has approved the allotment of 63,327 equity shares of ₹ 5/- each fully-paid, of the Company to the applicants, as detailed hereunder: - 47,977 equity shares, on exercise of stock options under the Employee Stock Option Plan 2014 (ESOP-2014). - 15,350 equity shares, on exercise of stock options under the Employee Stock Option Scheme 2018 ( by Capital Market - Live News
